Analysis on the clinical and endoscopic parameters in 1247 patients with reflux esophagitis
- 1 Department of Gastroenterology, General Hospital of Chinese People’s Armed Police Forces, Beijing, China
- 2 Department of Gastroenterology, General Hospital of Chinese People’s Armed Police Forces, Beijing, China
- 3 Department of Gastroenterology, General Hospital of Chinese People’s Armed Police Forces, Beijing, China
- 4 Department of Gastroenterology, General Hospital of Chinese People’s Armed Police Forces, Beijing, China
- 5 Department of Gastroenterology, General Hospital of Chinese People’s Armed Police Forces, Beijing, China
Abstract
Aim: To summarize and analyze the clinical and endoscopic parameters in patients with reflux esophagitis(RE). Methods : 1247 patients with RE were diagnosed in our hospital endoscopy center from September 2010 to August 2012 . The general information of the patients and the relationship between endoscopic classification and concomitant diseases were analyzed. Results : According to the endoscopic findings, 1247 subjects (4.70 %) were found to have RE : 932 (74.74%) males and 315 (25.26%) females, and the male to female ratio was 2.96:1. The peak age of prevalence was 50 to 59 (27.35%) which is followed by 40 to 49 (23.10%). In this study, most of the patients had a mild degree of esophagitis representing LA-A in 60.63% and LA-B in 34.24%. The antrum hyperemia was found in 291 patients with esophagitis (23.34%), followed by antrum erosion (20.13%) and hatal hernia (15.88%). There is no statistically significant relevance between Helicobacter pylori infection and RE (P > 0.05), but Barrett’s esophagus, duodenal ulcer , gastroesophageal tumors, a history of gastroesophageal surgery and antrum hyperemia were found to be associated with RE (P < 0.05) . Conclusion: The prevalence rate of endoscopic RE in our study was 4.70%, and most patients had a mild grade esophagitis. Male, advanced age, Barrett’s esophagus, duodenal ulcer, gastroesophageal tumors and a history of gastroesophageal surgery are the risk factors of esophagitis. Antrum hyperemia may reduce the severity of RE.
- Vakil, N., Van Zanten, S.V., Kahrilas, P., et al. (2006) The Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus. American Journal of Gastroenterology, 101, 1900-1920. http://dx.doi.org/10.1111/j.1572-0241.2006.00630.x
- Jung, H.-K. (2011) Epidemiology of gastroesophageal reflux disease in Asia: A systematic review. Journal of Neurogastroenterology and Motility, 17, 14-27. http://dx.doi.org/10.5056/jnm.2011.17.1.14
- Wang, P.-C., Hsu, C.-S., Tseng, T.-C., et al. (2012) Male sex, hiatus hernia, and Helicobacter pylori infection associated with asymptomatic erosive esophagitis. Journal of Gastroenterology and Hepatology, 27, 586-591. http://dx.doi.org/10.1111/j.1440-1746.2011.06881.x
- Shim, K.-N., Hong, S.J., Sung, J.K., et al. (2009) Clinical spectrum of reflux esophagitis among 25,536 Koreans who underwent a health check-up: A nationwide multi-center prospective, endoscopy-based study. Journal of Gastroenterology and Hepatology, 43, 632-638. http://dx.doi.org/10.1097/MCG.0b013e3181855055
- Kahrilas, P.J. and Boeckxstaens, G. (2012) Failure of reflux inhibitors in clinical trials: Bad drugs or wrong patients? Gut, 61, 1501-1509. http://dx.doi.org/10.1136/gutjnl-2011-301898
- Armstrong, D., Bennett, J.R., Blum, A.L., et al. (1996) The endoscopic assessment of esophagitis: A progress report on observer agreement. Gastroenterology, 111, 85-92. http://dx.doi.org/10.1053/gast.1996.v111.pm8698230
- Miwa, H., Yokoyama, T., Hori, K., et al. (2008) Interobserver agreement in endoscopic evaluation of reflux esophagitis using a modified Los Angeles classification incorporating grades N and M: A validation study in a cohort of Japanese endoscopists. Diseases of the Esophagus, 21, 355-363. http://dx.doi.org/10.1111/j.1442-2050.2007.00788.x
- Chinese Medical Association Society for Gastrointestinal Endoscopy (2000) Diagnosis and treatments of reflux esophagitis disease (inflammation) (Trial). Journal of Internal Medicine, 39, 2101.
- Liu, H.F. and Wang, W.A. (2009) Gastroesophageal reflux disease. Beijing Scientific and Technical Documents Publishing House, Beijing, 92-93.
- Fass, R. (2012) Therapeutic options for refractory gastroesophageal reflux disease. Journal of Gastroenterology and Hepatology, 27, 3-7. http://dx.doi.org/10.1111/j.1440-1746.2012.07064.x
- Zerbib, F. (2010) Medical treatment of GORD. Emerging therapeutic targets and concepts. Best Practice & Research Clinical Gastroenterology, 24, 937-946. http://dx.doi.org/10.1016/j.bpg.2010.08.009